# Aivfo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/aivfo

- Industry: Biotechnology
- Headquarters: Chengdu, China
- Website: www.aivfo.com
- Latest round: Series A (Aug 1, 2018)
- Investors on record: 1

## About

Aivfo is a biotechnology company focused on developing and applying advanced reproductive assistance technologies to enhance clinical solutions for fertility challenges.Founded in 2017 and headquartered in Chengdu, China, Aivfo specializes in advanced reproductive technologies. The company raised Series A funding in August 2018 from Suzhou Industrial Park Bioventure Investment Management. Fei Yan leads the company, bringing expertise in the biotechnology sector.Chengdu Aiweifu Biotechnology Co., Ltd. specializes in the development and application of advanced reproductive assistance technologies. The company’s core offering centers around clinical solutions designed to enhance the efficiency and safety of assisted reproductive procedures. These solutions cater to a diverse clientele, including fertility clinics, healthcare providers, and ultimately, couples seeking assistance with reproductive challenges. The technologies focus on improving outcomes in assisted reproduction, addressing issues such as infertility and genetic screening. Aiweifu's products are primarily marketed within China, with a growing interest in expanding their reach to international markets to enhance their service offerings globally.Chengdu Aiweifu Biotechnology Co., Ltd. generates revenue through direct transactions with fertility clinics and healthcare providers, delivering tailored clinical solutions that address specific needs in reproductive healthcare. The company structures its revenue model around B2B transactions, providing services that may involve partnerships with medical institutions seeking advanced reproductive technologies. Each clinical solution is strategically priced to reflect the technology's capabilities and the value it offers to end-users. Revenue streams may include service contracts, product sales, and consultation fees, establishing a robust financial ecosystem centered on high-quality reproductive healthcare services.Aivfo plans to design and launch new products targeting the enhancement of assisted reproductive technologies. The company aims to expand into international markets, focusing on regions such as Southeast Asia by 2025. The recent Series A funding raised in August 2018 will be utilized to support these product developments and market expansion initiatives.

## Funding rounds

- Series A, Aug 1, 2018 — YuanBio Venture

## Investors

- YuanBio Venture (https://capitalatlas.ai/funds/yuanbio-venture) — Series A